DelveInsight's 2025 report reveals a robust pipeline with 75+ companies developing 80+ therapies for chronic kidney disease, highlighting significant industry investment in addressing this growing health concern.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.